Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier(Tufts University), David M. Brown(Retina Consultants of Houston), Victor Chong(University of Oxford), Jean‐François Korobelnik(Université de Bordeaux), Peter K. Kaiser(Cleveland Eye Clinic), Quan Dong Nguyen(Johns Hopkins University), Bernd Kirchhof(University of Cologne), Allen C. Ho(Wills Eye Hospital), Yuichiro Ogura(Nagoya City University), George D. Yancopoulos(Regeneron (United States)), Neil Stahl(Regeneron (United States)), Robert Vitti(Regeneron (United States)), Alyson J. Berliner(Regeneron (United States)), Yuhwen Soo(Regeneron (United States)), Majid Anderesi(Bayer (Germany)), Georg Groetzbach(Bayer (Germany)), Bernd Sommerauer(Bayer (Germany)), Rupert Sandbrink(Bayer (Germany)), Christian Simader(Medical University of Vienna), Ursula Schmidt‐Erfurth(Medical University of Vienna)
Cited by 2,456
Abstract
Related Papers
Ranibizumab for Neovascular Age-Related Macular Degeneration
Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al.|New England Journal of Medicine|2006|5.9k
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
The CATT Research Group|New England Journal of Medicine|2011|2.6k
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin
Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group|Archives of Ophthalmology|1999|2.2k